We are developing microsystems that replicate aspects of blood vessel function to understand cell dysfunction and ultimately study disease initiation and cell interactions with varying materials. This will allow us to evaluate new drugs and novel therapies. These systems use human derived cells and therefore could potentially reduce the use of animals in pre-clinical testing of new therapies.